Evidence map›Paper›PMID 31801476›Full record

Observational studyBMC nephrology2019

Preventing acute kidney injury in high-risk patients by temporarily discontinuing medication - an observational study in general practice.

Suzanne J Faber, Nynke D Scherpbier, Hans J G Peters, Annemarie A Uijen

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Managing 'sick days' in patients with chronic conditions: An exploration of patient and healthcare provider experiences.Health expectations : an international journal of public participation in health care and health policy · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Suzanne J FaberDepartment of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Nynke D ScherpbierDepartment of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Hans J G PetersDepartment of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Annemarie A UijenDepartment of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Annemarie.Uijen@radboudumc.nl.ORCID 0000-0002-7703-6250
Radboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElderly, patients with chronic kidney disease (CKD) and patients with heart failure who continue using renin-angiotensin-aldosterone-system (RAAS) inhibitors, diuretics, or non-steroidal-anti-inflammatory drugs (NSAIDs) during times of fluid loss have a high risk of developing complications like acute kidney injury (AKI). The aim of this study was to assess how often advice to discontinue high-risk medication was offered to high-risk patients consulting the general practitioner (GP) with increased fluid loss. Furthermore, we assessed the number and nature of the complications that occurred after GP consultation.

methodsWe performed a cross-sectional study with patients from seven Dutch general practices participating in the Family Medicine Network between 1 and 6-2013 and 1-7-2018. We included patients who used RAAS-inhibitors, diuretics, or NSAIDs, and had at least one of the following risk factors: age ≥ 70 years, CKD, or heart failure. From this population, we selected patients with a 'dehydration-risk' episode (vomiting, diarrhoea, fever, chills, or gastrointestinal infection). We manually checked their electronic patient files and assessed the percentage of episodes in which advice to discontinue the high-risk medication was offered and whether a complication occurred in 3 months after the 'dehydration-risk' episode.

resultsWe included 3607 high-risk patients from a total of 44.675 patients (8.1%). We found that patients were advised to discontinue the high-risk medication in 38 (4.6%) of 816 'dehydration-risk' episodes. In 59 of 816 episodes (7.1%) complications (mainly AKI) occurred.

conclusionsDutch GPs do not frequently advise high-risk patients to discontinue high-risk medication during 'dehydration-risk' episodes. Complications occur frequently. Timely discontinuation of high-risk medication needs attention.

Indexed as

Acute Kidney InjuryAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAnti-Inflammatory Agents, Non-SteroidalDehydrationDeprescriptionsDiureticsAgedFemaleGeneral PracticeHeart FailureHumansMaleRenal Insufficiency, ChronicRisk AdjustmentRisk FactorsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAnti-Inflammatory Agents, Non-SteroidalDiureticsAcute kidney injuryChronic kidney diseaseDehydrationDeprescribingGeneral practice

Identifiers

PMID31801476
PMCPMC6894347
OpenAlexW2991796382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.